Deferred Tax Assets, Valuation Allowance of Organogenesis Holdings Inc. from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary: Organogenesis Holdings Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2017 to 31 Dec 2025.
Organogenesis Holdings Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $1,267,000.
Source SEC data: View on sec.gov

Deferred Tax Assets, Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Organogenesis Holdings Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$1,267,000			31 Dec 2025	10-K	26 Feb 2026	2025	FY
Q4 2020	$48,252,000	-$5,999,000	-11%	31 Dec 2020	10-K	01 Mar 2022	2021	FY
Q4 2019	$54,251,000	+$7,065,000	+15%	31 Dec 2019	10-K	16 Mar 2021	2020	FY
Q4 2018	$47,186,000	+$14,215,000	+43%	31 Dec 2018	10-K	09 Mar 2020	2019	FY
Q4 2017	$32,971,000			31 Dec 2017	10-K	18 Mar 2019	2018	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.